Markets:

Overview

News

Currencies

International

Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

17.94 -0.14 (-0.77%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about 10x Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

10x Genomics (TXG) Q3 2025 Earnings Transcript ↗

November 27, 2025

10x Genomics (TXG) Q3 2025 Earnings Transcript

Via The Motley Fool

BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government...

Via StockStory

Topics Economy Government

Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Analyst Expectations For 10x Genomics's Future ↗

October 23, 2025

Via Benzinga

3 Reasons to Avoid TXG and 1 Stock to Buy Instead

November 18, 2025

What a time it’s been for 10x Genomics. In the past six months alone, the company’s stock price has increased by a massive 73.9%, reaching $15.53 per share. This was partly thanks to its solid...

Via StockStory

1 Momentum Stock with Promising Prospects and 2 We Avoid

November 13, 2025

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...

Via StockStory

5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call

November 13, 2025

10x Genomics delivered results in Q3 that exceeded Wall Street’s expectations, driven by robust demand in spatial biology and a steady performance in single-cell consumables. Management attributed the...

Via StockStory

Topics Earnings

1 Small-Cap Stock for Long-Term Investors and 2 We Avoid

November 11, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Why 10x Genomics (TXG) Stock Is Trading Up Today

November 11, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 0.6% in the afternoon session after Canaccord Genuity Group raised its price target on the stock. The analyst firm lifted its target to $19.00...

Via StockStory

Topics Artificial Intelligence Supply Chain

Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3

November 10, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at PacBio (NASDAQ:PACB) and the best and worst...

Via StockStory

Topics Artificial Intelligence

3 Russell 2000 Stocks We Approach with Caution

November 09, 2025

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

Via StockStory

Topics Retirement

Why 10x Genomics (TXG) Stock Is Trading Up Today

November 07, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 14.3% in the afternoon session after the company reported third-quarter financial results that beat Wall Street's expectations and provided an...

Via StockStory

Topics Artificial Intelligence

TXG Q3 Deep Dive: Spatial Biology and Consumables Drive Outperformance Amid Macro Uncertainty

November 07, 2025

Biotech company 10x Genomics (NASDAQ:TXG) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 1.7% year on year to $149 million. On top of that, next quarter’s revenue guidance...

Via StockStory

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 07, 2025

Via Benzinga

10X Genomics (NASDAQ:TXG) Surges 13% on Q3 Revenue Beat and Strong Guidance ↗

November 06, 2025

10x Genomics (TXG) stock surged over 13% after beating Q3 2025 earnings estimates and providing strong Q4 revenue guidance, signaling investor optimism.

Via Chartmill

10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1%

November 06, 2025

Biotech company 10x Genomics (NASDAQ:TXG) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.7% year on year to $149 million. On top of that, next quarter’s...

Via StockStory

Mark Zuckerberg’s Chan Zuckerberg Initiative Bets Big on AI to Conquer All Diseases

November 06, 2025

The Chan Zuckerberg Initiative (CZI), founded by Priscilla Chan and Mark Zuckerberg, is placing artificial intelligence at the very heart of its audacious mission: to cure, prevent, or manage all...

Via TokenRing AI

Topics Artificial Intelligence

10x Genomics Earnings: What To Look For From TXG

November 04, 2025

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting results this Thursday after market hours. Here’s what investors should know.

Via StockStory

Lancaster Opens $7 Million Position in 10x Genomics (TXG) ↗

October 24, 2025

Lancaster Opens $7 Million Position in 10x Genomics (TXG)

Via The Motley Fool

3 Healthcare Stocks Walking a Fine Line

October 24, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

10x Genomics Partners With Anthropic To Bring AI Tools For Researchers ↗

October 20, 2025

10x Genomics is partnering with Anthropic to integrate its single cell and spatial biology analysis tools into Claude for Life Sciences.

Via Stocktwits

Topics Artificial Intelligence

Why Is 10x Genomics (TXG) Stock Rocketing Higher Today

October 20, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 6% in the morning session after BofA Securities maintained its "Buy" rating on the stock, even while lowering its price target.

Via StockStory

Topics Artificial Intelligence

Why 10x Genomics (TXG) Stock Is Trading Up Today

October 15, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 1.5% in the afternoon session after it announced a strategic partnership with SPT Labtech, a laboratory automation company, to provide...

Via StockStory

Topics Economy Government World Trade

Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns ↗

October 15, 2025

Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.

Via Benzinga

Topics Artificial Intelligence

3 Unprofitable Stocks with Questionable Fundamentals

October 13, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

Topics Artificial Intelligence

10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗

September 18, 2025

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of billions dollars in revenue.

Via Benzinga

3 Stocks Under $50 We Find Risky

September 16, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.